150 related articles for article (PubMed ID: 21095239)
1. Phosphorylation of Bcl-associated death protein (Bad) by erythropoietin-activated c-Jun N-terminal protein kinase 1 contributes to survival of erythropoietin-dependent cells.
Deng H; Zhang J; Yoon T; Song D; Li D; Lin A
Int J Biochem Cell Biol; 2011 Mar; 43(3):409-15. PubMed ID: 21095239
[TBL] [Abstract][Full Text] [Related]
2. JNK and p38 are activated by erythropoietin (EPO) but are not induced in apoptosis following EPO withdrawal in EPO-dependent HCD57 cells.
Jacobs-Helber SM; Ryan JJ; Sawyer ST
Blood; 2000 Aug; 96(3):933-40. PubMed ID: 10910907
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin-induced phosphorylation/degradation of BIM contributes to survival of erythroid cells.
Abutin RM; Chen J; Lung TK; Lloyd JA; Sawyer ST; Harada H
Exp Hematol; 2009 Feb; 37(2):151-8. PubMed ID: 19100675
[TBL] [Abstract][Full Text] [Related]
4. Jun N-terminal kinase promotes proliferation of immature erythroid cells and erythropoietin-dependent cell lines.
Jacobs-Helber SM; Sawyer ST
Blood; 2004 Aug; 104(3):696-703. PubMed ID: 15059850
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals.
Bose C; Udupa KB
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C394-405. PubMed ID: 18550701
[TBL] [Abstract][Full Text] [Related]
6. Unraveling distinct intracellular signals that promote survival and proliferation: study of erythropoietin, stem cell factor, and constitutive signaling in leukemic cells.
Sawyer ST; Jacobs-Helber SM
J Hematother Stem Cell Res; 2000 Feb; 9(1):21-9. PubMed ID: 10738968
[TBL] [Abstract][Full Text] [Related]
7. BAD Ser128 is not phosphorylated by c-Jun NH2-terminal kinase for promoting apoptosis.
Zhang J; Liu J; Yu C; Lin A
Cancer Res; 2005 Sep; 65(18):8372-8. PubMed ID: 16166315
[TBL] [Abstract][Full Text] [Related]
8. JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD.
Yu C; Minemoto Y; Zhang J; Liu J; Tang F; Bui TN; Xiang J; Lin A
Mol Cell; 2004 Feb; 13(3):329-40. PubMed ID: 14967141
[TBL] [Abstract][Full Text] [Related]
9. Phosphatase inhibition promotes antiapoptotic but not proliferative signaling pathways in erythropoietin-dependent HCD57 cells.
Lawson AE; Bao H; Wickrema A; Jacobs-Helber SM; Sawyer ST
Blood; 2000 Sep; 96(6):2084-92. PubMed ID: 10979952
[TBL] [Abstract][Full Text] [Related]
10. Opposing effects of Bad phosphorylation at two distinct sites by Akt1 and JNK1/2 on ischemic brain injury.
Wang XT; Pei DS; Xu J; Guan QH; Sun YF; Liu XM; Zhang GY
Cell Signal; 2007 Sep; 19(9):1844-56. PubMed ID: 17555943
[TBL] [Abstract][Full Text] [Related]
11. Distinct roles of JNKs/p38 MAP kinase and ERKs in apoptosis and survival of HCD-57 cells induced by withdrawal or addition of erythropoietin.
Shan R; Price JO; Gaarde WA; Monia BP; Krantz SB; Zhao ZJ
Blood; 1999 Dec; 94(12):4067-76. PubMed ID: 10590051
[TBL] [Abstract][Full Text] [Related]
12. ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD.
Shen J; Wu Y; Xu JY; Zhang J; Sinclair SH; Yanoff M; Xu G; Li W; Xu GT
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):35-46. PubMed ID: 19628748
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of Bad at Thr-201 by JNK1 promotes glycolysis through activation of phosphofructokinase-1.
Deng H; Yu F; Chen J; Zhao Y; Xiang J; Lin A
J Biol Chem; 2008 Jul; 283(30):20754-60. PubMed ID: 18469002
[TBL] [Abstract][Full Text] [Related]
14. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells).
Bao H; Jacobs-Helber SM; Lawson AE; Penta K; Wickrema A; Sawyer ST
Blood; 1999 Jun; 93(11):3757-73. PubMed ID: 10339482
[TBL] [Abstract][Full Text] [Related]
16. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells.
Sakamoto H; Kitamura T; Yoshimura A
J Biol Chem; 2000 Nov; 275(46):35857-62. PubMed ID: 10960479
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2.
Silva M; Grillot D; Benito A; Richard C; Nuñez G; Fernández-Luna JL
Blood; 1996 Sep; 88(5):1576-82. PubMed ID: 8781412
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective effect of erythropoietin in rats with acute myocardial infarction through JNK pathway.
Li GQ; Chen M
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(3 Suppl):153-160. PubMed ID: 31389586
[TBL] [Abstract][Full Text] [Related]
19. Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways.
Sui X; Krantz SB; Zhao ZJ
Br J Haematol; 2000 Jul; 110(1):63-70. PubMed ID: 10930980
[TBL] [Abstract][Full Text] [Related]
20. AP1 regulation of proliferation and initiation of apoptosis in erythropoietin-dependent erythroid cells.
Jacobs-Helber SM; Wickrema A; Birrer MJ; Sawyer ST
Mol Cell Biol; 1998 Jul; 18(7):3699-707. PubMed ID: 9632752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
